Primary tumor vascularity in esophagus cancer. CD34 and HIF1-α expression correlate with tumor progression

Histology and Histopathology

Volumn 28, Issue 10, 2013, Pages 1361-1368

  Goscinski, Mariusz Adam ^a   Nesland, Jahn Marthin ^a   Giercksky, Karl Erik ^a   Dhakal, Hari Prasad ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD34; Esophageal cancer; HIF1 ; Primary tumor vascularity; Survival

Indexed keywords

CD34 ANTIGEN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ANOXIA; ARTICLE; DISEASE COURSE; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TIME; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANOXIA; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84885339220     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baatar D., Jones M.K., Tsugawa K., Pai R., Moon W.S., Koh G.Y., Kim I., Kitano S. and Tarnawski A.S. (2002). Esophageal ulceration triggers expression of hypoxia-inducible factor-1 alpha and activates vascular endothelial growth factor gene: implications for angiogenesis and ulcer healing. Am. J. Pathol. 16, 1449-1457.
2. Balac I., Jurisic V., Laban A., Randelovic T., Knezevic P., Pantic I. and Dzodic R. (2012). The CD34-microvascular density in colorectal cancer patients. J. BUON 17, 97-101.
3. Begg A.C., Janssen H., Sprong D., Hofland I., Blommestijn G., Raleigh J.A., Varia M., Balm A., Van Velthuyzen L., Delaere P., Sciot R. and Haustermans K.M.G. (2001). Hypoxia and perfusion measurements in human tumors--initial experience with pimonidazole and IUdR. Acta Oncol. 40, 924-928.
4. Bhattacharyya A., Chattopadhyay R., Hall E.H., Mebrahtu S.T., Ernst P.B. and Crowe S.E. (2010). Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 299, 1177-1186.
5. Chen W.T. and Kelly T. (2003). Seprase complexes in cellular invasiveness. Cancer Metastasis Rev. 22, 259-269.
6. Dhakal H.P., Naume B., Synnestvedt M., Borgen E., Kaaresen R., Schlichting E., Wiedswang G., Bassarova A., Giercksky K.E. and Nesland J.M. (2008). Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination. Clin. Cancer Res. 148, 2341-2350.
7. Dhakal H.P., Bassarova A., Naume B., Synnestvedt M., Borgen E., Kaaresen R., Schlichting E., Wiedswang G., Giercksky K.E. and Nesland J.M. (2009). Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count. Histol. Histopathol. 24, 1049-1059.
8. El Gehani K., Al-Kikhia L., Mansuri N., Syrjänen K., Al-Fituri O. and Elzagheid A. (2011). Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31. Libyan J. Med. 10, 3402.
9. Enzinger P.C. and Mayer R.J. (2003). Esophageal cancer. N. Engl. J. Med. 349, 2241-2252.
10. Fidler I.J. and Ellis L.M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
11. Folkman J. (1986). How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res. 46, 467-473.
12. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M. and Semenza G.L. (2002). Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211.
13. Fukuda R., Kelly B. and Semenza G.L. (2003). Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63, 2330-2334.
14. Goscinski M.A., Suo Z.H., Nesland J.M., Chen W.T., Zakrzewska M., Wang J., Zhang S., Flørenes V.A. and Giercksky K.E. (2008a). Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China. Oncology 75, 49-59.
15. Goscinski M.A., Suo Z.H., Nesland J.M., Flørenes V.A. and Giercksky K.E. (2008b). Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines. APMIS 116, 823-831.
16. Goscinski M.A., Larsen S.G., Warloe T., Stoldt S., Nesland J.M., Suo Z.H. and Giercksky K.E. (2009). Adenocarcinomas on the rise -does it influence survival from oesophageal cancer? Scand. J. Surg. 98, 214-220.
17. Hansen S., Grabau D.A., Sørensen F.B., Bak M., Vach W. and Rose C. (2000). The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin. Cancer Res. 6, 139-146.
18. Hendriksen E.M., Span P.N., Schuurig J., Peters J.P.W., Sweep F.C.G.J., van der Kogel A.J. and Bussink J. (2009). Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc. Res. 77, 96-103.
19. Koshy M., Esiashvilli N., Landry J.C., Thomas C.R.Jr and Matthews R.H. (2004). Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 9, 147-159.
20. Koukourakis M.I., Giatromanolaki A., Sivridis E., Simopoulos C., Turley H., Talks K., Gatter K.C. and Harris A.L. (2002). Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 53, 1192-1202.
21. Koukourakis M.I., Giatromanolaki A., Sivridis E., Pastorek J., Karapantzos I., Gatter K.C. and Harris A.L. (2004). Tumour and Angiogenesis Research Group: Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 59, 67-71.
22. Krock B.L., Skuli N. and Simon M.C. (2011). Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2, 1117-1133.
23. Lee C.H., Lee M.K., Kang C.D., Kim Y.D., Park D.Y., Kim J.Y., Sol M.Y. and Suh K.S. (2003). Differential expression of hypoxia inducible factor-1 alpha and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas. J. Korean Med. Sci. 18, 196-203.
24. Liang J.T., Huang K.C., Jeng Y.M., Lee P.H., Lai H.S. and Hsu H.C. (2004) Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer. Br. J. Surg. 91, 355-361.
25. Moriyama N., Amano Y., Mishima Y., Okita K., Takahashi Y., Yuki T., Ishimura N., Ishihara S. and Kinoshita Y. (2008). What is the clinical significance of stromal angiogenesis in Barrett's esophagus? J. Gastroenterol. Hepatol. 23, 210-215.
26. Osinsky S., Bubnovskaya L., Ganusevich I., Kovelskaya A., Gumenyuk L., Olijnichenko G. and Merentsev S. (2011). Hypoxia, tumour-associated macrophages, microvessel density, VEGF and matrix metalloproteinases in human gastric cancer: interaction and impact on survival. Clin. Transl. Oncol. 13, 133-138.
27. Parkin D.M., Bray F., Ferlay J. and Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
28. Semenza G.L. (2011). Hypoxia. Cross talk between oxygen sensing and the cell cycle machinery. Am. J. Physiol. Cell Physiol. 550-552.
29. Semenza G.L. and Wang G.L. (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12, 5447-5454.
30. Shih C.H., Ozawa S., Ando N., Ueda M. and Kitajima M. (2000). Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus. Clin. Cancer Res. 1161-1168.
31. Tanigawa N., Matsumura M., Amaya H., Kitaoka A., Shimomatsuya T., Lu C., Muraoka R. and Tanaka T. (1997). Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79, 220-225.
32. Torres C., Wang H., Turner J., Shahsafaei A. and Odze R.D. (1999). Prognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinoma. Hum. Pathol. 30, 753-758.
33. UICC (2005). TNM Atlas: An illustrated guide to the TNM/pTNM classification of malignant tumors. Digestive system tumors, 5th ed. Springer. Heidelberg. pp 74-83.
34. Vermeulen P.B., Gasparini G., Fox S.B., Colpaert C., Marson L.P., Gion M., Beliën J.A., de Waal R.M., Van Marck E., Magnani E., Weidner N., Harris A.L. and Dirix L.Y. (2002). Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur. J. Cancer 38, 1564-1579.
35. Wahl P., Schmidt A., Demarees M., Achtzehn S., Bloch W. and Mester J. (2013). Responses of angiogenic growth factors to exercise, to hypoxia and to exercise under hypoxic conditions. Int. J. Sports Med. 34, 95-100.
36. Wang T., Leng Y.F., Zhang Y., Xue X., Kang Y.Q. and Zhang Y. (2011). Oxidative stress and hypoxia-induced factor 1· expression in gastric ischemia. World J. Gastroenterol. 17, 1915-1922.
37. Weidner N. (1995). Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res. Treat. 36, 169-180.
38. Weidner N. (1998). Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J. Pathol. 184, 119-122.
39. WHO (1990). Histological typing of esophageal and gastric tumors. Geneva. pp 20-26.
40. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L. and Simons J.W. (1999). Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res. 59, 5830-5835.